iBio will use blockchain tech to cut costs and improve traceability in a deal that may also see Mateon spin-out a biopharma AI specialist.
Plant-based biologics CDMO iBio asked EdgePoint AI – a unit of Mateon Therapeutics – to install artificial intelligence (AI) technologies at its manufacturing facility in Bryan, Texas.
The idea is that the systems – known as TrustPoint Vision Fabric and TrustPoint Smart Protocols – will monitor production operations conducted and store data in a “blockchain.”
A blockchain is a digital record of transactions that can be viewed but not edited. In a drug manufacturing plant, it can track the transfer of raw materials from one unit operation to the next.
According to iBio initial deployment will be in raw material supply chain related functions.
The system will be used to automate the tracking of materials from time of receipt to manufacturing introduction...